In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform - Wikidata - wikimedia - TriplyDB

In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform

In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform

http://www.wikidata.org/entity/Q26767210

about

In Vitro Co-Culture Models of Breast Cancer Metastatic Progression towards Bone Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.Modeling nasopharyngeal carcinoma in three dimensions A microfluidics assay to study invasion of human placental trophoblast cells Zebrafish models for functional and toxicological screening of nanoscale drug delivery systems: promoting preclinical applications.Looking to the future of organs-on-chip Quantitative Proteomic and Phosphoproteomic Comparison of 2D and 3D Colon Cancer Cell Culture Models.Mesenchymal Stem Cells Relevance in Multicellular Bioengineered 3D In vitro Tumor Models.Effect of shear stress on iPSC-derived human brain microvascular endothelial cells (dhBMECs).Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment.Engineered Microvessels for the Study of Human Disease Targeted adjuvant therapy in breast cancer.Tissue-engineered 3D microvessel and capillary network models for the study of vascular phenomena.Architecture in 3D cell culture: An essential feature for in vitro toxicology.Biomimetic strategies to recapitulate organ specific microenvironments for studying breast cancer metastasis.Tumour-on-a-chip: microfluidic models of tumour morphology, growth and microenvironment.Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing.In silico characterization of cell-cell interactions using a cellular automata model of cell culture.Microchamber Cultures of Bladder Cancer: A Platform for Characterizing Drug Responsiveness and Resistance in PDX and Primary Cancer Cells.Culture conditions defining glioblastoma cells behavior: what is the impact for novel discoveries?A Microdevice Platform Recapitulating Hypoxic Tumor Microenvironments.Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening.Fabrication of low-cost micropatterned polydimethyl-siloxane scaffolds to organise cells in a variety of two-dimensioanl biomimetic arrangements for lab-on-chip culture platforms.In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.Road to stemness in hepatocellular carcinoma.Biomaterial Substrate-Mediated Multicellular Spheroid Formation and Their Applications in Tissue Engineering.Mitosis-Mediated Intravasation in a Tissue-Engineered Tumor-Microvessel Platform.Are we ready to take full advantage of patient-derived tumor xenograft models?The Influence of Hyaluronic Acid and Glioblastoma Cell Coculture on the Formation of Endothelial Cell Networks in Gelatin Hydrogels.Assessing chemotherapeutic effectiveness using a paper-based tumor model.Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?A pH-Sensing Optode for Mapping Spatiotemporal Gradients in 3D Paper-Based Cell Cultures.Role of Microenvironment in Glioma Invasion: What We Learned from In Vitro Models.Dissemination from a Solid Tumor: Examining the Multiple Parallel Pathways.Pancreatic cancer: Current status and Challenges.In silico cancer research towards 3R.Nanoparticle delivery to metastatic breast cancer cells by nanoengineered mesenchymal stem cells.Novel 3D Liquid Cell Culture Method for Anchorage-independent Cell Growth, Cell Imaging and Automated Drug Screening.Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy.Preservation of the 3D Phenotype Upon Dispersal of Cultured Cell Spheroids Into Monolayer Cultures.

P2860

Q26738435-34DF36B8-0292-43E9-A7D5-55E44590020B Q30239861-5319495D-F4A8-49B3-AD35-AC439350C797 Q33599243-14CB41E6-BA44-4EEE-9F07-E53F31C8222F Q33753692-26F38C46-F89D-4FEC-A06A-1A826D22BEC4 Q33775916-6042D189-2FEF-478F-A27F-4B53A57CA912 Q33827214-EAC7036B-8832-4CF7-8625-6E819AF354D8 Q38442240-73EC2B44-92E4-4B07-B196-78A46B9B7D0F Q38638108-17E37114-2044-4CBB-BE00-2818C952DBEF Q38695766-CF70CCE5-DCD4-45CF-883C-EFD34AB6393B Q38810462-BBB3061D-CBF1-48B6-960F-62BA1E83495B Q38930761-3A30D517-D806-42EF-A444-BDDC9AFD4DA3 Q38980703-923DA0FA-5893-4389-B737-7F7C9DFB7F64 Q39121501-25940AF1-98C6-49AD-8CEA-CAE5BF200DEE Q39213995-B2AFADB1-AEBD-4F52-87EA-51984EC7245E Q39260571-F86C1B97-C325-4CBD-91B0-AD28F36FFB96 Q39388967-81F697DC-5F80-412A-BF8A-145252DB8FBA Q41007674-BAEBC038-29A7-4FB6-B7DB-9932FDC6C610 Q41034382-40971F6D-F1F7-4351-B9F2-D9247423ADC6 Q42363687-8B3AA1BB-E974-4A86-94A5-8E579B3831DC Q42366669-39528DC8-B83F-42A1-AE18-6A5F4E41F216 Q46768239-36CA6ADF-A49F-4017-93A5-698671B5B1D5 Q46914962-4C37475E-E197-408E-9728-81E5899D4593 Q47109871-9605AE62-4038-4A2B-8ABF-4F80D4C82FA9 Q47119905-1F595CE3-6AFC-4BBF-8F36-E61FC2695FB9 Q47137381-D752530C-48FF-4898-8870-AA327E649631 Q47660648-F5E3C006-5EF0-445E-88A1-093D72564DC7 Q47661828-F513D3FB-9CDC-4DFB-B58B-AE5774B6B53E Q48099042-97A588CB-5D10-4038-B201-4674F2B8D5FD Q48100097-2595AE96-7272-4CF7-A66E-FA0DB3A2526C Q48135600-419F1C62-A25A-490A-98D8-D051D40D557D Q48218832-E7F32501-0D99-4854-B21A-065C7A72233D Q48261867-ED00ED5C-CA78-4D0D-B089-A323CCB97573 Q48310787-70B18360-20D0-4C0F-84C1-8480C841C361 Q50138593-C93A58B9-574D-417D-B361-E7FC0B226015 Q50195669-F1B499B1-2029-411E-8545-152EABF88526 Q52323287-26F4297C-808F-45A5-9E9C-7D71E2571813 Q52668037-3DF89D78-76FA-49E2-9209-001011F22B74 Q52684315-5F66BA63-3F94-4EEA-8540-938A5C23AD61 Q52722792-3DD69A11-8335-4638-9E53-9A19537015A7 Q52864755-EBB8EFC2-1EFA-46E8-BBDC-93136BFFBA72

P2860

In Vitro Tumor Models: Advantages, Disadvantages, Variables, and Selecting the Right Platform

http://www.wikidata.org/entity/Q26767210

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

In Vitro Tumor Models: Advanta ...... d Selecting the Right Platform

@ast

In Vitro Tumor Models: Advanta ...... d Selecting the Right Platform

@en

In Vitro Tumor Models: Advanta ...... d Selecting the Right Platform

@nl

type

label

In Vitro Tumor Models: Advanta ...... d Selecting the Right Platform

@ast

In Vitro Tumor Models: Advanta ...... d Selecting the Right Platform

@en

In Vitro Tumor Models: Advanta ...... d Selecting the Right Platform

@nl

prefLabel

In Vitro Tumor Models: Advanta ...... d Selecting the Right Platform

@ast

In Vitro Tumor Models: Advanta ...... d Selecting the Right Platform

@en

In Vitro Tumor Models: Advanta ...... d Selecting the Right Platform

@nl

P1433

Q26767210-7DE1D423-1FC3-49B0-8E43-FE75D5010532

P1476

Q26767210-C968CFD1-3CA6-4571-82D4-9BE466338646

P2093

Q26767210-05C1551B-D886-4B8B-859D-EF1D308B6E98

Q26767210-2DA25D77-C58E-41B9-A9C0-3A2DBBD2A03A

Q26767210-6230EDA4-976E-4733-B0DD-40DF9E706461

Q26767210-9C376727-A12C-4027-A28E-01BFC87846E4

Q26767210-E604B1D3-6AF4-425C-98DB-3748F3416406

P2860

Q26767210-021511DF-FFE5-4781-B13F-AD5DCCC95065

Q26767210-02B79195-1B32-4DC1-A3AE-BA56DB206662

Q26767210-055D73F9-10DE-48A9-BCD1-9EE6C26AD3A9

Q26767210-077B4409-3309-40CC-BD2C-945C485313C8

Q26767210-07AFF38C-DA79-4E67-ABAB-54350C98E277

Q26767210-08C990D4-F0FD-4B67-BC07-DECB9A48A348

Q26767210-0A868532-4472-41B7-9542-AB6A3F56EE4B

Q26767210-0CFAF4B3-7D9A-41FB-9097-A921AF88E85C

Q26767210-0F675F6C-98BC-413B-9418-3C0D60F2A81E

Q26767210-1361C158-E147-4BDE-AC2B-BD53A2CB53FE

P304

Q26767210-B8BDCED5-25C4-46F6-980E-8C9992D3D2A8

P31

Q26767210-EBF56253-2179-49EF-A205-567FCFE6F0B7

P3181

Q26767210-0E18855A-FA8C-4C91-A7F7-35C44213AD3B

P356

Q26767210-A01D3DE3-6FA3-4F44-A0D0-82B4C753505C

P407

Q26767210-96564779-1F03-43EE-85AE-53107BD06DC6

P478

Q26767210-5A91215B-F8E1-4199-8A3B-B6330BE67B94

P577

Q26767210-BFC7E262-E3E4-47FF-A756-F93D9086301E

P5875

Q26767210-51B263CE-3191-4E5D-9759-D460D00B5599

P698

Q26767210-06039F45-BC9D-4140-8C6A-36F18FF183A9

P932

Q26767210-15AB4BA8-C4C0-4D42-B356-ED2ABC9CE014

P3181

P356

FBIOE.2016.00012

P1433

Frontiers in Bioengineering and Biotechnology

P1476

In Vitro Tumor Models: Advanta ...... d Selecting the Right Platform

@en

P2093

Amanda L Placone

http://www.w3.org/2001/XMLSchema#string

Andrew D Wong

http://www.w3.org/2001/XMLSchema#string

Moriah E Katt

http://www.w3.org/2001/XMLSchema#string

Peter C Searson

http://www.w3.org/2001/XMLSchema#string

Zinnia S Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

The Cancer Genome Atlas Pan-Cancer analysis project

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

An integrated in vitro model of perfused tumor and cardiac tissue

Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy

Innate and adaptive immune cells in the tumor microenvironment

Cancer invasion and the microenvironment: plasticity and reciprocity

3D Traction forces in cancer cell invasion

Cooperative roles of SDF-1α and EGF gradients on tumor cell migration revealed by a robust 3D microfluidic model

The blockade of immune checkpoints in cancer immunotherapy

P304

12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3887867

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FBIOE.2016.00012

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

294088299

http://www.w3.org/2001/XMLSchema#string

P698

26904541

http://www.w3.org/2001/XMLSchema#string

P932

4751256

http://www.w3.org/2001/XMLSchema#string